Innovative exergaming technology for older adults in long-term care homes
Developing and Assessing an Innovative Exergaming Technology for Older Adults Living in Long-term Care Homes With a User-centered Design Approach
This study is testing a new gaming exercise program called MouvMat to see if it can help older adults in long-term care homes stay active and improve their well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | University of Toronto Academic / other |
| Locations | 2 sites (Toronto and 1 other locations) |
| Trial ID | NCT05130203 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and assess a new exergaming technology called MouvMat, designed to engage older adults living in long-term care homes in physical activity through gamified exercises. The intervention will involve a randomized control trial with 56 residents, where participants will be assigned to either the exergaming group or a standard recreational programming group. The study will also include interviews with LTC staff and family members to evaluate the technology's acceptability, usability, and enjoyment. By addressing physical inactivity and cognitive decline, this approach seeks to enhance the overall well-being of older adults in these settings.
Who should consider this trial
Good fit: Ideal candidates for this study are residents aged 55 and older living in long-term care homes who can communicate in English.
Not a fit: Patients who are unable to communicate in English or do not have the capacity to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could significantly improve the physical and cognitive health of older adults in long-term care, reducing risks of depression and dementia.
How similar studies have performed: Other studies have shown positive outcomes with exergaming interventions for older adults, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All residents at the participating long-term care homes are eligible if they are 55 years of age or older * Ability to communicate and speak English * Able to provide informed consent or have a substitute decision maker (SDM) who provides informed consent * A family member, friend, or personally-hired caregiver of an older adult residing in one of our participating LTC facilities are eligible to participate if they are 18 years of age or older, can communicate and speak English * The LTC resident does not need to be enrolled in or study in order for their family member/friend/caregiver to participate * LTC staff are eligible if they can communicate and speak English, are currently working in one of the participating LTC facilities, have at least 6 months experience working with older adults in LTC, providing or supervising physical or recreational activities, or involved with purchasing or directing these activities, and are a member of one of the following professions/positions: physiotherapist, physiotherapy assistant, recreational therapist, or LTC administrator. Exclusion Criteria: * Residents will be ineligible to participate in the study is they cannot communicate or speak English * Residents who typically do not participate in recreational activities * Residents who have a severe sensory (e.g., deaf, blind) or severe to moderate cognitive impairment AND/OR scores less than 20 on the Mini- Mental Status Examination (MMSE) * Family Members who cannot communicate or speak English * Family Members who cannot interact with the MouvMat due to sensory limitations (i.e., severe visual or auditory impairment) * Family Members who cannot provide verbal feedback
Where this trial is running
Toronto and 1 other locations
- Chester Village — Toronto, Canada (Completed)
- Kensington Gardens — Toronto, Canada (Recruiting)
Study contacts
- Principal investigator: Charlene Chu, PhD — University of Toronto
- Study coordinator: Charlene Chu, PhD
- Email: charlene.chu@utoronto.ca
- Phone: 416-946-0217
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.